Literature DB >> 34457228

Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the HGF/PTEN/Wnt/β-catenin axis.

Jun Zhang1, Guoliang Jia1, Pan Xue1, Zhengwei Li2.   

Abstract

BACKGROUND: Previous studies reported that melatonin exerts its effect on mesenchymal stem cell (MSC) survival and differentiation into osteogenic and adipogenic lineage. In the current study we aimed to explore the effect of melatonin on osteoporosis and relevant mechanisms.
METHODS: Real-time qualitative polymerase chain reaction (RT-qPCR) and Western blot analysis were conducted to determine expression of HGF, PTEN, and osteoblast differentiation-related genes in ovariectomy (OVX)-induced osteoporosis mice and the isolated bone marrow MSCs (BMSCs). Pre-conditioning with melatonin (1 μmol/l, 10 μmol/l and 100 μmol/l) was carried out in OVX mice BMSCs. Bone microstructure was analyzed using micro-computed tomography and the contents of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase 5b (TRAP5b) were detected by enzyme-linked immunosorbent assay in serum. BMSC proliferation was measured by cell-counting kit (CCK)-8 assay. Alizarin red S (ARS) staining and ALP activity assay were performed to assess BMSC mineralization and calcification. The activity of the Wnt/β-catenin pathway was evaluated by dual-luciferase reporter assay.
RESULTS: Melatonin prevented bone loss in OVX mice. Melatonin increased ALP expression and reduced TRAP5b expression. HGF and β-catenin were downregulated, while PTEN was upregulated in the femur of OVX mice. Melatonin elevated HGF expression and then stimulated BMSC proliferation and osteogenic differentiation. Additionally, HGF diminished the expression of PTEN, resulting in activated Wnt/β-catenin pathway both in vitro and in vivo. Furthermore, melatonin was shown to ameliorate osteoporosis in OVX mice via the HGF/PTEN/Wnt/β-catenin axis.
CONCLUSION: Melatonin could potentially enhance osteogenic differentiation of BMSCs and retard bone loss through the HGF/PTEN/Wnt/β-catenin axis.
© The Author(s), 2021.

Entities:  

Keywords:  HGF; PTEN; Wnt/β-catenin; bone marrow mesenchymal stem cells; melatonin; osteoporosis

Year:  2021        PMID: 34457228      PMCID: PMC8392808          DOI: 10.1177/2040622321995685

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN: 2040-6223            Impact factor:   5.091


  36 in total

1.  Synthesis, In Vitro Antitumor Activity and Molecular Mechanism of Novel Furan Derivatives and their Precursors.

Authors:  Dan Lu; Ya Zhou; Qin Li; Juan Luo; Qihua Jiang; Baicheng He; Qiang Tang
Journal:  Anticancer Agents Med Chem       Date:  2020       Impact factor: 2.505

2.  Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment.

Authors:  Ze-Ping Hu; Xiao-Ling Fang; Bo Sheng; Ying Guo; Yong-Qiang Yu
Journal:  Vascul Pharmacol       Date:  2020-02-15       Impact factor: 5.773

Review 3.  An old method facing a new challenge: re-visiting housekeeping proteins as internal reference control for neuroscience research.

Authors:  Rena Li; Yong Shen
Journal:  Life Sci       Date:  2013-02-27       Impact factor: 5.037

4.  MiR-221 and miR-26b Regulate Chemotactic Migration of MSCs Toward HGF Through Activation of Akt and FAK.

Authors:  Aisi Zhu; Naixin Kang; Lihong He; Xianyang Li; Xiaojing Xu; Huanxiang Zhang
Journal:  J Cell Biochem       Date:  2015-11-24       Impact factor: 4.429

Review 5.  Osteoporosis.

Authors:  Kristine E Ensrud; Carolyn J Crandall
Journal:  Ann Intern Med       Date:  2017-08-01       Impact factor: 25.391

6.  Melatonin up-regulates bone marrow mesenchymal stem cells osteogenic action but suppresses their mediated osteoclastogenesis via MT2 -inactivated NF-κB pathway.

Authors:  Yi Zhou; Chaowei Wang; Jinyan Si; Baixiang Wang; Denghui Zhang; Ding Ding; Jian Zhang; Huiming Wang
Journal:  Br J Pharmacol       Date:  2020-02-12       Impact factor: 8.739

Review 7.  Generation of circadian rhythms in the suprachiasmatic nucleus.

Authors:  Michael H Hastings; Elizabeth S Maywood; Marco Brancaccio
Journal:  Nat Rev Neurosci       Date:  2018-08       Impact factor: 34.870

8.  Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling.

Authors:  De-Zhi Tang; Wei Hou; Quan Zhou; Minjie Zhang; Jonathan Holz; Tzong-Jen Sheu; Tian-Fang Li; Shao-Dan Cheng; Qi Shi; Stephen E Harris; Di Chen; Yong-Jun Wang
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

9.  Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.

Authors:  Gengyang Shen; Hui Ren; Qi Shang; Wenhua Zhao; Zhida Zhang; Xiang Yu; Kai Tang; Jingjing Tang; Zhidong Yang; Xiaobing Jiang
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

10.  Abnormal osteogenic and chondrogenic differentiation of human mesenchymal stem cells from patients with adolescent idiopathic scoliosis in response to melatonin.

Authors:  Chong Chen; Caixia Xu; Taifeng Zhou; Bo Gao; Hang Zhou; Changhua Chen; Changli Zhang; Dongsheng Huang; Peiqiang Su
Journal:  Mol Med Rep       Date:  2016-06-10       Impact factor: 2.952

View more
  8 in total

Review 1.  The circadian clock has roles in mesenchymal stem cell fate decision.

Authors:  Wenzhen Gao; Rong Li; Meilin Ye; Lanxin Zhang; Jiawen Zheng; Yuqing Yang; Xiaoyu Wei; Qing Zhao
Journal:  Stem Cell Res Ther       Date:  2022-05-16       Impact factor: 8.079

Review 2.  The Role of SIRT3 in the Osteoporosis.

Authors:  Siwang Hu; Shuangshuang Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-25       Impact factor: 6.055

Review 3.  Assessment of the Therapeutic Potential of Melatonin for the Treatment of Osteoporosis Through a Narrative Review of Its Signaling and Preclinical and Clinical Studies.

Authors:  Yongchao Zhao; Guoxi Shao; Xingang Liu; Zhengwei Li
Journal:  Front Pharmacol       Date:  2022-05-11       Impact factor: 5.988

4.  The effect of melatonin on the mouse ameloblast-lineage cell line ALCs.

Authors:  Jing Pan; Qianhui Ren; Zhao Yang; Ying Guo; Kubin Kwon; Checheng Shen; Yueying Wang; Fang Ji
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

Review 5.  Melatonin and the Programming of Stem Cells.

Authors:  Rüdiger Hardeland
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

6.  Melatonin increases bone mass in normal, perimenopausal, and postmenopausal osteoporotic rats via the promotion of osteogenesis.

Authors:  Huanshuai Guan; Ning Kong; Run Tian; Ruomu Cao; Guanzhi Liu; Yiyang Li; Qilu Wei; Ming Jiao; Yutian Lei; Fangze Xing; Peng Tian; Kunzheng Wang; Pei Yang
Journal:  J Transl Med       Date:  2022-03-16       Impact factor: 5.531

7.  Bindarit Reduces Bone Loss in Ovariectomized Mice by Inhibiting CCL2 and CCL7 Expression via the NF-κB Signaling Pathway.

Authors:  Shi-Guo Yuan; Hong-Ling Hu; Xin-Jia Wang; Jin-Cheng Yang; Rong-Ping Zhou; Xiao-Chun Bai; Ping-Lin Lai
Journal:  Orthop Surg       Date:  2022-04-26       Impact factor: 2.279

8.  Melatonin Accelerates Osteoporotic Bone Defect Repair by Promoting Osteogenesis-Angiogenesis Coupling.

Authors:  Sheng Zheng; Chunhao Zhou; Han Yang; Junhua Li; Ziyu Feng; Liqing Liao; Yikai Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-22       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.